Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
BioBlast®
Biosimilars Deals 2023
Diversity
Masterclasses
Other Podcasts
Other Updates
Our Awards
Patent Case Summaries
Patent Litigation
Patents
PipCast®
PTE
Trade Marks
Webinars
Joanne Grant

Anna Stines PhD

Special Counsel, Patent Attorney

PhD, MIP, BSc (Hons)
Doctor of Philosophy (Plant Biochemistry and Molecular/Cell Biology)
Master of Intellectual Property Law
Bachelor of Science (Molecular and Cell Biology)(Hons)
Registered Patent Attorney (AU, NZ)

Anna joined the patent profession over 20 years ago and is a registered Patent Attorney with extensive experience providing strategic advice and guiding biotechnology and pharmaceutical patents to grant in Australia and New Zealand.

Anna has extensive experience working with local and international clients on a wide range of intellectual property matters.  Anna particularly enjoys solving complex problems, developing strategies and assisting clients in the areas of structural biology, protein engineering, genetics, genomics, antibody therapeutics, peptide and gene-based therapies and diagnostics, pharmaceuticals, transgenic plants, vaccine formulations and microbially-driven technologies.

Prior to joining Pearce IP as a Special Counsel, Anna was a Partner and Principal of specialist IP firm Pizzeys Patent and Trade Mark Attorneys.

Anna’s PhD project was focused on characterising the molecular biology and biochemistry of amino acid biosynthesis during grape berry ripening.  The research was carried out at the CRC for Viticulture together with the University of Adelaide in order to investigate the effect of amino acid accumulation in grape berries on the wine fermentation process.

After completing her PhD, Anna’s postdoctoral work involved a proteomics-bases investigation of molecular chaperone assisted protein folding in mammalian and bacterial systems at the Max-Plank Institute for Biochemistry in Munich.

My Awards

Chambers and Partners

Intellectual Property: Pearce IP (2024)

Australian Law Awards (Lawyers Weekly)

Finalist – Boutique Diversity Firm of the Year:  Pearce IP (2022)
Finalist – Intellectual Property Team of the Year: Pearce IP (2022)
Winner – Intellectual Property Team of the Year: Pearce IP (2021)

IAM Patent 1000

Firm: Pearce IP ranked bronze for litigation and prosecution (2022)
Firm: Pearce IP ranked bronze for litigation and recommended for prosecution (2021)

Managing IP Stars

Firm: Pearce IP ranked – Tier 3 prosecution (2022)

Women in Business Law Awards – APAC

Shortlisted: Australian Firm of the Year (2022)

Australasian Lawyer 5-Star Awards

5-Star Intellectual Property Law Firm: Pearce IP (2021)

Lexology Legal Influencer

Healthcare and Life Sciences (Australasia): Pearce IP (Q2 2022, Q1 2021, Q4 2020)
Healthcare and Life Sciences (Cross-border): Pearce IP (2021)

Legal 500

Ranked as a market leading Intellectual Property firm (2023)

 

"Winner - Intellectual Property Team of the Year 2021"

Australian Law Awards (Lawyers Weekly)

"Finalist - Intellectual Property Team of the Year 2022"

Australian Law Awards (Lawyers Weekly)

"Pearce IP ranked bronze for litigation and recommended for prosecution"

IAM Patent 1000 (2021)

"Pearce IP ranked bronze for litigation and prosecution"

IAM Patent 1000 2022

"5-Star Intellectual Property Law Firm"

Australasian Lawyer 5-Star Awards 2021

"Pearce IP Ranked Tier 3 - Prosecution"

MIP IP Stars 2022

"Lexology Legal Influencer"

Healthcare and Life Sciences (Australasia): Pearce IP (Q2 2022, Q1 2021, Q4 2020)

Healthcare and Life Sciences (Cross-border): Pearce IP (2021)

"Women in Business Law Awards - APAC"

Shortlisted: Australian Firm of the Year (2022)

The Legal 500, 2023, Intellectual Property, Australia

The Pearce IP team has an in depth understanding of the science and the pharmaceutical regulatory industry driving many of their client’s businesses.  They are passionate about achieving their client’s commercial objectives – and they are extremely hard-working and dedicated lawyers.

OUR VISION

By 2027, be the premier life sciences IP practice in
Australia and New Zealand.